CRESUD S.A.-SPONS ADR (CRESY)

US2264061068 - ADR

7.67  +0.03 (+0.39%)

After market: 7.67 0 (0%)

Fundamental Rating

4

Overall CRESY gets a fundamental rating of 4 out of 10. We evaluated CRESY against 92 industry peers in the Food Products industry. CRESY has an excellent profitability rating, but there are concerns on its financial health. CRESY is valied quite expensively at the moment, while it does show a decent growth rate.



7

1. Profitability

1.1 Basic Checks

In multiple years CRESY reported negative net income over the last 5 years.
CRESY had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of CRESY (3.38%) is comparable to the rest of the industry.
CRESY has a better Return On Equity (19.17%) than 87.91% of its industry peers.
With a Return On Invested Capital value of 3.01%, CRESY perfoms like the industry average, outperforming 48.35% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CRESY is significantly below the industry average of 8.76%.
The last Return On Invested Capital (3.01%) for CRESY is above the 3 year average (1.24%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.38%
ROE 19.17%
ROIC 3.01%
ROA(3y)0.99%
ROA(5y)-0.33%
ROE(3y)-6.05%
ROE(5y)-31.99%
ROIC(3y)1.24%
ROIC(5y)1.35%

1.3 Margins

With an excellent Profit Margin value of 23.04%, CRESY belongs to the best of the industry, outperforming 96.70% of the companies in the same industry.
CRESY's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 21.02%, CRESY belongs to the best of the industry, outperforming 98.90% of the companies in the same industry.
CRESY's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 42.52%, CRESY belongs to the top of the industry, outperforming 95.60% of the companies in the same industry.
CRESY's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 21.02%
PM (TTM) 23.04%
GM 42.52%
OM growth 3Y-15.85%
OM growth 5Y6.83%
PM growth 3Y23.52%
PM growth 5Y27.63%
GM growth 3Y3.55%
GM growth 5Y2.3%

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, CRESY has less shares outstanding
The number of shares outstanding for CRESY has been increased compared to 5 years ago.
CRESY has a better debt/assets ratio than last year.

2.2 Solvency

The Debt to FCF ratio of CRESY is 17.56, which is on the high side as it means it would take CRESY, 17.56 years of fcf income to pay off all of its debts.
CRESY has a Debt to FCF ratio (17.56) which is comparable to the rest of the industry.
CRESY has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.14, CRESY is doing worse than 72.53% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 17.56
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.18 indicates that CRESY should not have too much problems paying its short term obligations.
With a Current ratio value of 1.18, CRESY is not doing good in the industry: 63.74% of the companies in the same industry are doing better.
A Quick Ratio of 0.89 indicates that CRESY may have some problems paying its short term obligations.
CRESY has a Quick ratio (0.89) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.89

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 335.64% over the past year.
The Earnings Per Share has been growing by 41.72% on average over the past years. This is a very strong growth
The Revenue has grown by 224.92% in the past year. This is a very strong growth!
CRESY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.34% yearly.
EPS 1Y (TTM)335.64%
EPS 3Y50.26%
EPS 5Y41.72%
EPS Q2Q%-353.02%
Revenue 1Y (TTM)224.92%
Revenue growth 3Y32.29%
Revenue growth 5Y15.34%
Sales Q2Q%531.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The decent profitability rating of CRESY may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.55%, CRESY is a good candidate for dividend investing.
CRESY's Dividend Yield is rather good when compared to the industry average which is at 3.74. CRESY pays more dividend than 97.80% of the companies in the same industry.
CRESY's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 8.55%

5.2 History

CRESY has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of CRESY decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

140.48% of the earnings are spent on dividend by CRESY. This is not a sustainable payout ratio.
DP140.48%
EPS Next 2YN/A
EPS Next 3YN/A

CRESUD S.A.-SPONS ADR

NASDAQ:CRESY (7/26/2024, 7:23:30 PM)

After market: 7.67 0 (0%)

7.67

+0.03 (+0.39%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap452.75M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 8.55%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.38%
ROE 19.17%
ROCE
ROIC
ROICexc
ROICexgc
OM 21.02%
PM (TTM) 23.04%
GM 42.52%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.18
Quick Ratio 0.89
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)335.64%
EPS 3Y50.26%
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)224.92%
Revenue growth 3Y32.29%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y